Pharmaceutical

Alfasigma to buy Intercept Pharmaceuticals for $794m

Alfasigma has signed a definitive agreement for the acquisition of Intercept Pharmaceuticals in an all-cash deal valued at $794m.

Sep 27, 2023 - 20:00
Alfasigma to buy Intercept Pharmaceuticals for $794m
Alfasigma has signed a definitive agreement for the acquisition of Intercept Pharmaceuticals in an all-cash deal valued at $794m.
Read the original article

Tags:

Previous Article

MilliporeSigma opens two new mRNA manufacturing facilities in Germany

Next Article

Morphic’s EMERALD-1 trial for ulcerative colitis disappoints

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Amicus gears up to launch Pompe disease combination therapy in the UK

Amicus gears up to launch Pompe disease combination the...

Aug 16, 2023

ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?

ASCO24: Can Ambrx’s novel ADC break into the metastatic...

Jun 4, 2024

Q&A: How can the US maintain access to essential drugs?

Q&A: How can the US maintain access to essential drugs?

Jun 29, 2023